Roche and its subsidiary TIB Molbiol have developed three different LightMix® Modular Virus kits for the detection of the monkeypox virus- Multiple clusters of monkeypox virus have been reported in non-endemic countries, and the
World Health Organization (WHO ) expects more cases will be identified as surveillance expands - Use of these new research test kits assess the spread of the virus and can help monitor the potential impact of therapeutics, vaccines and public health interventions
“Roche has very quickly developed a new suite of tests that detect the monkeypox virus and aid in following its epidemiologic spread,” said Thomas Schinecker, CEO
The first LightMix Modular Virus kit detects orthopoxviruses, including all monkeypox viruses from both the West African and Central African forms of the virus (referred to as clades).The second kit is a specific test detecting monkeypox viruses only (West African and Central African clade). For researchers interested in obtaining both of these results, a third kit is available that simultaneously detects orthopoxviruses plus provides information on whether a monkeypox virus is present or not (West African and Central African clade).
The test kits are available for research use in the majority of countries worldwide.
About the LightMix® Modular Orthopox / MonkeypoxVirus kits
The LightMix® Modular Orthopox /Monkeypox Virus Kits are assays that detect Orthopoxviruses, including the monkeypox virus, using a technology called quantitative PCR (qPCR). To do this, first sample using an established NA extraction method. The assay is then performed on either a LightCycler® 480 II Instrument or cobas z 480 Analyzer. The kit, reagents and instruments are all available to purchase from the majority of
About the virus
Monkeypox was first detected in laboratory monkeys in 1958. The virus is, however, assumed to transmit from wild animals such as rodents to people — or from human to human. In an average year, a few thousand cases occur in Western and
About
Founded in 1896 in
In recognising our endeavor to pursue a long-term perspective in all we do,
For more information, please visit www.roche.com.
All trademarks used or mentioned in this release are protected by law.
References
[1] Kozlov, M., Monkeypox goes global: why scientists are on alert.
Roche Group Media Relations
Phone: +41 61 688 8888 / e-mail: media.relations@roche.com
Hans Trees, PhD Phone: +41 61 687 41 47 | Sileia Urech Phone: +41 79 935 81 48 |
Dr. Phone: +41 61 687 89 67 | Karsten Kleine Phone: +41 61 682 28 31 |
Nina Mählitz Phone: +41 79 327 54 74 | Nathalie Meetz Phone: +41 61 687 43 05 |
Attachment
- 25052022_MR_monkeypoxTest_en
© OMX, source